We are pleased to announce the successful merger and acquisition of MD Biosciences by MLM Medical Labs in Moenchengladbach, Germany, and Memphis, TN. MD Biosciences is a global, industry-leading provider of preclinical, translational, and clinical-phase contract research services for the development of pharmaceutical and diagnostic assets. The combination of our strong scientific backgrounds and unique experience will give our clients greater flexibility of services and maximum support at every phase, in both Europe and the USA. Dr. Lisa K. Jennings now serves as the Chief Scientific Officer for MLM and the Managing Director of both US-based MLM locations. Dr. Jennings noted that, "The addition of MD Biosciences to the global MLM Medical Labs family validates our dedication to provide science-driven, comprehensive laboratory services. Together, we look forward to further expanding our global expertise to assist in the advancement and approval of effective and innovative drugs and devices." Read the full press release below.